ФОРМИРОВАНИЕ БИОПЛЕНКИ МИКРООРГАНИЗМАМИ И ИХ ЗНАЧЕНИЕ В МЕДИЦИНЕ

Синетар Э. А.

ОБЗОРЫ ЛИТЕРАТУРЫ

Научная статья.

Обзор посвящен актуальной эпидемиологической, клинической и микробиологической проблеме возникновения, развития и распространения возбудителей госпитальных инфекций. Представлены новые материалы об этапах формирования биопленок на различных материалах, в частности мочевой катетер. Показаны методические возможности использования новых знаний об образовании биопленок ведущими возбудителями инфекций мочевыводящих путей для разработки и внедрения антиадгезивных лекарственных препаратов природного и синтетического происхождения.

микроорганизмы, биопленка, мочевые катетеры

1. Golovko SV. Klinichni aspekty kateter-asocijovanoi’ bakteriurii’. Vijs’kova medycyna Ukrai’ny. 2005;2(5):74-80. [in Ukrainian].
2. Bouza EА. European perspective on nosocomial urinary tract infections II. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI 004 study). Clin. Microbiol. Infect. 2001;7(10):532-42.
3. Shulutko EM, Bulanov AJu, Kljasova GA. Kateter-associirovannaja infekcija mochevyvodjashhih putej: faktory riska i metody profilaktiki. Vestn. intensivnoj terapii. 2005;4:73-7. [in Russian].
4. Sernjak JuP, Fukszon AS, Roshchin YuV, Kryshtap MV. Problema kateter-associirovannyh infekcij mochevogo trakta i bakterial’nyh biologicheskih plenok v sovremennoj urologii. Zdorov’e muzhchiny. 2005;2:40-4. [in Russian].
5. Mohamed JA, Huang DB. Biofilm formation by enterococci. J Med Microbiol. 2007;12(56):1581-8.
6. Xu W, Flores-Mireles AL, Cusumano ZT, Takagi E, Hultgren SJ, Caparon MG. Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinary tract infection. NPJ Biofilms Microbiomes. 2017;6:3-28.
7. Gostev VV, Sydorenko SV. Bakterial’nyye bioplenki i infektsii. Zhurnal infektologii. 2010;3(2):4-15. [in Russian].
8. O’Toole G, Kaplan NV, Kolter R. Biofilm formation as microbial development. Annu. Rev. Microbiol. 2000;54:49-79.
9. Dobrokhotskiy ON, Khomyakov YuN, Khomyakova TI. Epidemiologicheskoye znachenie formirovanija bioplenok v tehnicheskih sistemah. Zhizn’ bez opasnostej. Zdorov’e. Profilaktika. Dolgoletie. 2008;4:78-80. [in Russian].
10. Donlon RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002;15:167-93.
11. Flemming HC, Neu TR, Wozniak DJ. The EPS matrix: the “house of biofilm cell”. J. Bacteriol. 2007;22(189):7945-7.
12. Salmanov AH, Mariyevskyy VF, Boyko VV, Ioffe IV, Taraban IA. Antybiotykorezystentnist v khirurhiyi: Monohrafiya NTMT Kharkiv; 2012. 431 s. [in Ukrainian].
13. Randall D, Wolcott MD, Garth D, Ehrlich PhD. Biofilms and chronic Infections. JAMA. 2008;299(22):2682-4.
14. Chambless J, Hunt S, Stewart P. A three-dimensional computer model of four hypothetical mechanisms protecting biofilms from antimicrobials. Appl Environ Microbiol. 2006;72(3):2005-13.
15. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol. 2005;13(1):34-40.
16. Vorobyey YeS, Voronkova OS, Vinnikov AI. Bakterialni bioplivky. Quorum sensing – “vidchuttya kvorumu» u bakteriy v bioplivkakh. Visnyk Dnipropetrovskoho universytetu. Biolohiya. Ekolohiya. 2012;1(20):13-22. [in Ukrainian].
17. Ivanytsya VO, Halkin MB. Suchasni uyavlennya shchodo mekhanizmiv formuvannya bioplivky. Mikrobiolohiya i biotekhnolohiya. 2011;2:8-22. [in Ukrainian].
18. Hentzer M, Givskov M, Eberl L. Quorum sensing in biofilms: gossip in slimecity. In: Ghannoum M., and O’Toole G.A., eds., Microbial biofilms. Washington. D.C.: ASM Press. 2004:118-40.
19. Miller MB, Bassler BL. Quorum sensing in bacteria. Annu. Rev. Microbiol. 2001;55:165-99.
20. Chen X, Schauder S, Potier N, Van Dorsselaer A, Pelczer I, Bassler BL, et al. Structural identification of a bacterial quorum-sensing signal containing boron. Nature. 2002;415:545-9.
21. Jakobsen TH, van Gennip M, Christensen LD, Bjarnsholt T, Givskov M. Qualitative and quantitative determination of quorum-sensing inhibition in vitro. Quorum-sensing: methods and protocols. Methods in Molecular Biology. 2011;692:253-63.
22. Vinnik YuS, Per’yanova OV, Onzul’ YeV, Teplyakova OV. Mikrobnyye bioplenki v khirurgii: mekhanizmy obrazovavaniya, lekarstvennaya ustoychivost’, puti resheniya problemy. Novosti khirurgii. 2010;6(8):115-25. [in Russian].
23. Cogan NG, Keener JP. The role of the biofilm matrix in structural development. Mathem. Med. And Biol. 2004;2(21):147-66.
24. Sutherland IW. The biofilm – an immobilized but dynamic microbial environment. Trends in Microbiology. 2001;5(9):222-7.
25. Chebotar’ IV, Mayanskiy AN, Konchakova YeD, Lazareva AV, Chistyakovo VP. Antibiotikorezistentnost’ bioplonochnykh bakteríy. Klin. mikrobiol. antimikrob. khimioter. 2012;1(14):51-7. [in Russian].
26. Chebotar’ IV, Gur’yev YeL. Laboratornaya diagnostika klinicheski znachimykh bioplenochnykh protsessov. Voprosy diagnostiki v pediatrii. 2012;4(4):15-20. [in Russian].
27. Gabrielyan NI, Gorskaya YeM, Romanova NI, Tsirul’nikova OM. Gospital’naya mikroflora i bioplenki. Vestnik transplantologii i iskusstvennykh organov. 2012;3(14):83-91. [in Russian].
28. Rishpana MS, Kabbin JS. Candiduria in Catheter Associated Urinary Tract Infection with Special Reference to Biofilm Production. J. Clin. Diagn. Res. 2015;9(10).
29. Mokiyenko AV, Pushkina VA. Bioplenki i nozokomial’nyye infektsii: k otsenke vzaimosvyazi. Voda: gigiyena i yekologiya. 2013;1(1):141-58. [in Russian].
30. Trautner BW, Darouiche RO. Role of biofilm in catheter-associated urinary tract infection. Am. J. Infect. Control. 2004;3(32):177-83.
31. Lyamin AV, Botkin YeA, Zhestkov AV. Metody vyyavleniya bioplenok v meditsine: vozmozhnosti i perspektivy. Klin. mikrobiol. antimikrob. khimioter. 2012;1(14):17-22. [in Russian].
32. Nikolayev YuA, Plakunov VK. Bioplenka – «gorod mikrobov» ili analog mnogokletochnogo organizma? Mikrobioligiya. 2007;2(76):149-63. [in Russian].
33. Murugan K, Selvanayaki K, Al-Sohaibani S. Urinary catheter indwelling clinical pathogen biofilm formation, exopolysaccharide characterization and their growth influencing parameters. Saudi J Biol Sci. 2016;23(1):150-9.
34. Tenke P, Kovac B, Johansen Bjerklund TE, Matsumoto T, Tamby PA, Naber KG. Yevropeysko-Aziatskiye rekomendatsii po vedeniyu patsiyentov s infektsiyami, svyazannymi s uretral’nym kateterom, i po profilaktike kateter-assotsiirovannykh infektsiy. Klinich. mikrobiologiya i antimikrobnaya khimioterapiya. 2008;3(10):201-15. [in Russian].
35. Synetar EА, Avdyeyeva LV. Stupin prykriplennya klityn C. albicans do poverkhni medychnykh kateteriv z riznykh polimernykh materialiv. Hihiyena naselenykh mists. 2014;63:320-4. [in Ukrainian].
36. Synetar EА, Brych OI. Dynamika bioplivkovoho obroshchennya kateteriv Enterococcus faecalis. Visnyk Dnipropetrovskoho universytetu. Biolohiya. Medytsyna. 2015;6(2):146-50. [in Ukrainian].
37. Synetar EА, Avdyeyeva LV, Skoryk MA, Brych OI. Formuvannya bioplivky Candida albicans na poverkhni medychnykh kateteriv: doslidzhennya in vitro. Dovkillya ta zdorovya. 2014;1(68):28-32. [in Ukrainian].
38. Adaptovana klinichna nastanova z krashchoyi praktyka, diahnostyky, likuvanya tu profilaktyky infektsoho sechovyi sitey u zhinok [Internet]. Ukrayinkyy zhurnal nefrolhiyi toy dialzet. 2012;2(34):53-80. [in Ukrainian].
39. Kerivnytstvo Yevropeyskoyi asotsiatsiyi urolohiv z likuvannya infektsiyi sechovoyi systemy. Ukrayinskyy zhurnal nefrolohiyi ta dializu. 2017;2:53-9. [in Ukrainian].
40. Argumenty i fakty v nefrologii. Adgeziya bakteriy kak faktor uropatogenosti pri infektsiyakh mochevykh putey [Internet]. Ukraí̈ns’kiy medichniy chasopis. 2014;6(104):88. [in Ukrainian].
41. Shifris IM, Dudar IO, Loboda OM, Krot VF, Krasyuk EK, Bryzhachenko TP, ta in. Infektsiyi sechovoyi systemy u doroslykh: shlyakhy optymizatsiyi kompleksnoyi terapiyi. Semeynaya medytsyna. 2016;5(67):18-25. [in Ukrainian].
42. Dobryk OO, Secunda MO, Derkach IM, Gorgota OM, Halaniya CE, Dobrik DS. Suchasni pidkhody do likuvannya infektsiyi sechovykh shlyakhiv u ditey z urakhuvannyam utvorennya bakterialnykh bioplivok. Zdorove rebenka. 2017;4(12):475-85. [in Ukrainian].
43. Synetar EO, Loskutova MM. Vplyv preparatu «Aflazyn®» na adhezyvni vlastyvosti mikroorhanizmiv – zbudnykiv kateter-asotsiyovanykh infektsiy. Zdorove zhenshchyny. 2013;3(79):210-3. [in Ukrainian].
44. Synetar EO, Pokas OV, Avdyeyeva LV. Vplyv nanoselenu na bioplivkoutvorennya E. faecalis i C. albicans v asotsiatsiyi. Dovkillya ta Zdorovya. 2014;4(71):42-5. [in Ukrainian].

«Вестник проблем биологии и медицины» Выпуск 2 (144), 2018 год, 59-63 страницы, код УДК 579.22:577.151.6-083.1/532.692

10.29254/2077-4214-2018-2-144-59-63